ClinicalTrials.gg
TerminatedNCT03885492BabySaverUpdated Oct 25, 2023

The Baby-Saver Kit: Clinical Testing of a Device for Neonatal Resuscitation With Intact Cord in Uganda

An observational study in Birth Asphyxia, Neonatal Resuscitation and Maternal Distress, sponsored by Sanyu Africa Research Institute. Terminated at 1 site in Uganda. Open to female participants aged 15 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-25.

Sponsored by Sanyu Africa Research Institute · Observational

Why this study was terminated
This was part of a University of Liverpool PhD programme, but PI suspended by University and left the programme. Also dismissed by sponsoring organisation SAfRI. Likely unreliable data so project abandoned with no plans to publish.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
47
Ages
15 Years to 50 Years
Sex
Female
01

Study summary

To examine the usability, safety and acceptability of the BabySaver kit: a novel device for neonatal resuscitation in a low-income region in Africa

Read the detailed description

The BabySaver kit will be used for any delivery in which the baby requires resuscitation according to the hospital policy, national guidelines(Ministry of Health, 2016) and WHO policy(World Health Organization, 2014)

The target sample size for observation will be 30 babies requiring resuscitation at Mbale Regional Referral Hospital Delivery suite.

The researchers will observe midwives and mothers during the process of resuscitation. This will be a non-participant observation. The researchers will collect data on: demographics, the timing of cord clamping, time to establish ventilation, intervention provided on the kit, post-resuscitation temperature, need to move the baby to provide extra care, and notes of the ease of use or challenges experienced with the kit. The researchers will ask health workers for their views of the usability of the kit in comparison to the equipment in current use.

The researchers have developed a usability checklist to assess how health workers are using the BabySaver kit.

02

Conditions studied

  • Birth Asphyxia
  • Neonatal Resuscitation
  • Maternal Distress

Browse trials for

03

In context

Asphyxia Neonatorum

106 studies on the registry are indexed under Asphyxia Neonatorum; 19 are open to participants now.

This study's enrollment of 47 is below the median of 200 across 27 observational studies indexed under Asphyxia Neonatorum.

Browse Asphyxia Neonatorum studies →

Lead sponsor

Sanyu Africa Research Institute is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The BabySaver kit will be used for any delivery in which the baby requires resuscitation according to the hospital policy, national guidelines(Ministry of Health, 2016) and WHO policy(World Health Organization, 2014). These include

  • Deliveries before 37 weeks of gestation
  • Deliveries with evidence of fetal distress from fetal monitoring
  • Instrumental deliveries
  • Deliveries in which there is a possibility of a life-threatening malformation
  • Deliveries in which meconium stained liquor has been noted.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • As this is the first delivery suite to use the kit in a clinical setting, we will include only low-risk babies in this study. Every low-risk birth that will need neonatal resuscitation will be selected and observations made for the use of the BabySaver resuscitation kit.

Exclusion criteria

Exclusion Criteria:

  • High risk deliveries will be excluded, namely

    • babies born before 34 weeks' gestation,
    • babies with life threatening malformations or significant intrapartum asphyxia
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
47 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Change from 10 minutes in post-resuscitation temperature at 30 minutes

    The researcher will measure post resuscitation temperatures at 10, 20 and 30 minutes afterbirth for babies not admitted to the neonatal unit after using the BabySaver.

    Time frame: Between 10 and 30 minutes after birth

  2. Number of procedures performed to newborns while on the BabySaver kit

    The researcher will list any resuscitation procedures or interventions provided to the newborns on the kit.

    Time frame: at birth, upto 30 minutes

  3. change from childbirth in post-resuscitation temperature at admission to Neonatal unit.

    For babies admitted to the neonatal unit, the baby's temperature will be measured on admission to the Neonatal unit

    Time frame: Upon admission to Neonatal unit, up to 1 hour after birth

Secondary outcomes

  1. change from birth in Apgar score at 5 minutes

    Apgar score will be recorded at 1 minute and 5 minutes. Resuscitation of babies at birth will be performed in line with existing hospital guidelines.

    Time frame: upto 5 minutes

  2. Demographic assessments

    Researchers will collect both mother's (age, marital status, education, occupation) and baby's demographic characteristics (sex, birth weight, gestation at birth).

    Time frame: baseline

  3. Design assessments transcripts

    Researchers will collect data about design and practical aspects of the BabySaver kit from mothers, carers, midwives and doctors in form of audio and video recordings and extra notes. These will be transcribed verbatim for analysis using an NVivo qualitative software.

    Time frame: uptown 2 months

07

Study locations

1 site
  • Mbale Regional Referral hospital
    Mbale, Uganda
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03885492
Lead sponsor
Sanyu Africa Research Institute
Collaborators
University of Liverpool, Grand Challenges Canada, Mbale Regional Referral Hospital, Makerere University
Responsible party
Sponsor
First posted
Mar 21, 2019
Start date
Nov 1, 2020
Primary completion
Apr 1, 2021
Completion
Apr 1, 2021
Last update
Oct 25, 2023

Study contacts

Andrew D Weeks, MD
study chair · University of Liverpool

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion